Capital Group Investment Management Pte »

Crispr Therapeutics shares owned by Capital Group Investment Management Pte

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Capital Group Investment Management Pte from 13F filings

Historical chart of Capital Group Investment Management Pte investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Capital Group Investment Management Pte consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Capital Group Investment Management Pte

Quarter filed Position value Share count Share price at filing
2023-09-30 $956k 21k 45.39
2023-06-30 $1.2M 21k 56.14
2023-03-31 $928k 21k 45.23
2022-12-31 $808k 20k 40.65